Alliance Pharma PLC, a growing consumer healthcare company, has released its Annual Report & Accounts for the year ended 31 December 2023. The report is available on the company's website, and printed copies have been sent to shareholders who opted out of electronic communications. Additionally, the Notice of the 2024 Annual General Meeting, scheduled for 29 July 2024, has been made available on the website and mailed to relevant shareholders. Both documents can also be obtained by contacting Burson Buchanan. Alliance Pharma aims to empower people to make a positive difference to their health and wellbeing by making trusted and proven brands available worldwide. The company focuses on organic growth, investing in priority brands and channels, innovation, and selective geographic expansion. With around 285 employees across Europe, North America, and the Asia Pacific region, Alliance Pharma remains asset-light by outsourcing manufacturing and logistics.